Fonte: The New England Journal of Medicine. Unidade: FMRP
Assuntos: INFARTO DO MIOCÁRDIO, FIBRINÓLISE, ANTICOAGULANTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANTMAN, Elliott M. et al. Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction. The New England Journal of Medicine, v. 354, p. 1477-1488, 2006Tradução . . Acesso em: 18 ago. 2024.APA
Antman, E. M., Morrow, D. A., McCabe, C. H., Murphy, S. A., Ruda, M., Sadowsky, Z., et al. (2006). Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction. The New England Journal of Medicine, 354, 1477-1488.NLM
Antman EM, Morrow DA, McCabe CH, Murphy SA, Ruda M, Sadowsky Z, Budaj A, López-Sendón JL, Guneri S, Jiang F, White HD, Fox KAA, Braunwald E, Marin-Neto JA. Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction. The New England Journal of Medicine. 2006 ; 354 1477-1488.[citado 2024 ago. 18 ]Vancouver
Antman EM, Morrow DA, McCabe CH, Murphy SA, Ruda M, Sadowsky Z, Budaj A, López-Sendón JL, Guneri S, Jiang F, White HD, Fox KAA, Braunwald E, Marin-Neto JA. Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction. The New England Journal of Medicine. 2006 ; 354 1477-1488.[citado 2024 ago. 18 ]
